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Introduction 
 
Cyclopamine (11-deoxojervine) is a chemical derived from 
the plant Veratrum californicum and is known to induce 
cyclopia when ingested. Cyclopia is a birth defect that is 
characterized by the absence of median facial structures and 
holoprosencephaly (an undivided forebrain), which arise 
from abnormal patterning of the ventral neural tube. This 
defect is sometimes observed in the offspring of cattle that 
graze in a field in which Veratrum californicum is present. 
Cyclopamine was often ingested by humans in the past, 
because it is similar in appearance to the plant hellebore, 
which is occasionally given to women to prevent cramps, 
vomiting, and nausea during pregnancy (1). 
Cyclopamine works by preventing Sonic hedgehog 
(Shh) signaling, which is necessary for many aspects of 
development, including those mentioned above. Cyclopia 
can also occur by mutations in the Shh gene. The incidence 
of cyclopia occurs in about one in 250 embryos, and one in 
16,000 newborns. Inhibition of Shh signaling is not the only 
way to induce holoprosencephaly. A number of 
environmental factors are also known to elicit 
holoprosencephaly related malformations. Preconceptual 
diabetes, retinoic acid exposure, maternal alcohol 
consumption, and cholesterol synthesis inhibitors can all 
lead to varying severities of holoprosencephaly phenotypes 
(2). 
Shh signaling can be inhibited in several ways. A 
mutation in the Shh gene will cause the whole signaling 
pathway to not occur, because Shh is not made. The Shh 
pathway works by binding Shh to the patched protein, 
located on the membrane of a cell. When this happens, the 
smoothened protein, which is normally inhibited by patch, 
becomes uninhibited and releases the Ci protein from 
microtubules. The Ci protein enters the nucleus and acts as 
a transcriptional activator of particular genes. When Shh 
does not bind to patched, smoothened protein, it cannot be 
activated and the pathway cannot take place (3). 
Cyclopamine prevents Shh signaling by binding to a 
particular part of the smoothened protein called the 
heptahelical bundle, preventing it from functioning and 
allowing for the release of Ci protein from the microtubules 
(4).  
Another way for Shh signaling to be inhibited is 
through cholesterol synthesis inhibitors, as mentioned 
above. Cholesterol is of extreme importance to this pathway. 
It is necessary for the catalytic cleavage of the Shh protein 
but is also crucial in Shh’s function as a paracrine factor. 
Cholesterol binds to the active N-terminus of the Shh protein 
and allows it to diffuse over a wide area. Without cholesterol, 
this diffusion is severely hampered (3). While some argue 
that cyclopamine works by these mechanisms as well, 
others have shown that its teratogenic effects are solely due 
to interaction with the smoothened protein (5). Cyclopamine 
is also known to have clinical applications, mainly in 
instances in which Shh signaling needs to be inhibited. It is 
used in the treatment of medulloblastomas, which is the 
most common malignant brain tumor in children. The 
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malignant growth of these tumors can be halted by inhibiting 
the Shh signaling pathway with cyclopamine in mice and 
humans (6).  
In our experiment, we wanted to determine the 
effects of cyclopamine administration on craniofacial 
development and observe to what extent cyclopamine 
induces cyclopia in developing chick embryos. Shh is 
necessary for patterning of the neural ventral tube, as 
mentioned above. The ventral pattern is imposed by the 
notochord, which releases Shh. Formation of the ventral 
midline is also mediated by Shh released from the floor plate 
of the neural tube once this is formed (7). Commissural 
neurons help set up and cross the ventral midline in order to 
coordinate left and right motor activities. While Shh is not the 
only molecule involved in this process, it is crucial for guiding 
the commissural neurons and setting up the ventral midline. 
As a consequence of this, holoprosencephaly can occur (3). 
Also, the separation of the eye field into two bilateral fields 
depends on the secretion of Shh from the prechordal plate. 
When this is not released, Pax6 cannot be inhibited and the 
visual field will not be divided into two eyes. Because of the 
necessity of Shh signaling in the above mentioned events, 
we propose that inhibition of Shh signaling will lead to 
cyclopia and holoprosencephaly in cyclopamine treated 
animals. 
Another role of Shh signaling is in osteogenesis, 
or bone formation. Endochondral ossification is the type of 
bone formation by which the vertebrae, limbs and ribs 
develop. This type of bone formation requires the formation 
of cartilage, which is later turned into bone. The ventral part 
of the somite becomes the sclerotome. Shh induces 
sclerotome cells to express Pax1, which signals 
mesenchymal cells to become cartilage. The somites give 
rise to the vertebrae and limbs, so when somites cannot 
properly develop in order to give rise to cartilage, bone 
formation of the vertebrae and ribs cannot take place. We 
will stain cyclopamine treated chicks using alcian blue, a 
cartilage stain, in order to see if rib and vertebrae 
development can take place. We hypothesize that this will 
not happen due to the non specification of the somites. 
 
Methods 
 
Thirty fertilized chicken eggs were obtained from Phil’s Fresh 
Eggs. Eggs were incubated in a 13°C incubator until ready 
for treatment. Eggs spent ten days in the incubator before 
treatment began. 1 mg of cyclopamine was obtained from 
Sigma Aldridge. Cyclopamine was prepared and 
administered at doses comparable to the protocol of 
Incardona et al (1). Cyclopamine was complexed with 2-
hydroxypropyl-ß-cyclodextrin (HBC) in order to make the 
cyclopamine dissolve in Dulbecco’s phosphate buffered 
saline (DPBS). Cyclopamine-HBC was produced by 
suspending 1 mg of cyclopamine in 1 ml of 45% HBC in 
sterile DPBS and stirring for 3 hours at 60°C. After this, the 
solution was stored at room temperature and treatment 
began.  
Eggs were incubated in a 25°C incubator for 5-6 
hours until they reached stage one of development. At this 
point, eggs were removed from the incubator and some of 
the egg white was removed by inserting a syringe into the 
blunt side of the egg and extracting the fluid. Following this, 
eggs were windowed and the embryo was located. 5µg of 
cyclopamine was delivered to the embryos in a 5µl solution 
of HBC-DPBS, which was simply dropped onto the vitelline 
membrane using a pipette. Eggs were given a few drops of 
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sterile Ringer’s solution in order to prevent infection from 
occurring. Eggs were closed using a glass coverslip and 
tape in order to prevent drying out of the egg. They were 
placed back in the incubator and allowed to further develop. 
17 eggs were treated and 13 were not windowed at all, 
serving as controls. Eggs were held up to a bright light to 
check for blood vessel formation and viability after 48 hours. 
Chicks were allowed to further develop until they reached 
the 11 day stage. At this point, viable chicks were removed 
from their eggs and placed in TCA for alcian blue staining. 
The alcian blue staining procedure was performed as 
described in class (8). 
Eggs were incubated in a 25°C incubator for 5-6 
hours until they reached stage one of development. At this 
point, eggs were removed from the incubator and some of 
the egg white was removed by inserting a syringe into the 
blunt side of the egg and extracting the fluid. Following this, 
eggs were windowed and the embryo was located. 5µg of 
cyclopamine was delivered to the embryos in a 5µl solution 
of HBC-DPBS, which was simply dropped onto the vitelline 
membrane using a pipette. Eggs were given a few drops of 
sterile Ringer’s solution in order to prevent infection from 
occurring. Eggs were closed using a glass coverslip and 
tape in order to prevent drying out of the egg. They were 
placed back in the incubator and allowed to further develop. 
17 eggs were treated and 13 were not windowed at all, 
serving as controls. Eggs were held up to a bright light to 
check for blood vessel formation and viability after 48 hours. 
Chicks were allowed to further develop until they reached 
the 11 day stage. At this point, viable chicks were removed 
from their eggs and placed in TCA for alcian blue staining. 
The alcian blue staining procedure was performed as 
described in class (8). 
A second group of eggs was treated as well. 30 
eggs were obtained, and 10 were treated at stage one, when 
embryos were 5-6 hours old. 10 more embryos were treated 
at stage nine of development, when embryos were 28 hours 
old. For this second group of animals, a small hole was 
made in the vitelline membrane into which the 5µl 
cyclopamine solution was injected. Chicks were placed back 
in the incubator until they reached day 11 of development. 
These were also removed and processed for alcian blue 
staining. Remaining control eggs were placed back in the 
13°C incubator to prevent them from reaching full gestation 
and hatching. 
 
Results 
 
Overall Viability after Treatment 
After chicks were treated with cyclopamine and placed in the 
incubator, they were checked for viability 48 hours after 
treatment by being held up to a bright light to check for blood 
vessel formation. 17 embryos were originally windowed, but 
only 15 of these were treated, because an embryo was not 
detected in 2 of the eggs windowed. Of the 15 embryos 
treated, 4 appeared to be viable after 48 hours. 9 of the 13 
control eggs were viable at this point. At day 11 of 
development, chicks were removed from their eggs and 
processed for alcian blue staining. The 4 treated chicks were 
used for staining, as well as 4 control animals. Before the 
staining process was even started, it was not difficult to 
identify the treated animals from the control animals. All of 
the control animals appeared to be normal 11 days old 
chicks (Figure 1.A). Animals treated with cyclopamine, 
however, were much smaller than normal 11 day chicks and 
were hardly identifiable as such (Figure 1.B-E). The body 
length of an 11 day control animal was approximately 2.2 cm 
compared to about 1 cm for the treated chicks (Figure 1). 
In the second group of animals, where 10 were treated at 
stage 1 and 10 were treated at stages 9-10, we also 
Figure 1.A-E. 11 day control embryo stained with alcian blue(A).  
cyclopamine treated, underdeveloped 11 day embryos stained with 
alcian blue (B-E). 
 
checked for viability after 2 days. At this point, 2 of the chicks 
treated at stage 1 and 2 of the chicks treated at stage 9 were 
viable. Most of the chicks, however, failed to establish 
circulation and experienced arrested development. At day 
11, none of the embryos treated at stage 1 were viable. The 
black coloration of the matter in the egg was an indication of 
this. Both of the animals treated in stage 9 were viable after 
11 days and were processed for alcian blue staining at this 
point. One of these chicks, like the original 4 treated animals, 
was not nearly developed to the correct size of an 11 day 
embryo. However, one of the chicks developed slightly larger 
(body length of about 1.5 cm), but not to the size of a control 
11 day chick (Figure 2). These chicks were also processed 
for alcian blue staining. 
 
 
Figure 2. Cyclopamine treated chick with cyclopia (left) and control 
embryo (right), both stained with alcian blue. 
 
Alcian Blue Staining 
Alcian blue staining was performed on all of the treated 
animals and 4 of the controls. In 3 of the stage 1 animals 
and 1 of the stage 9 treated animals, no staining could be 
observed, except for in the eyes of the chicks. 1 of the stage 
1 treated animals developed larger than the other and 
showed some blue staining but not to the extent of a control 
chick at this stage. Some limb development had taken place 
in this chick (Figure 1.B), but there was no clear staining of 
the ribs or spinal cord. Alcian blue staining also revealed 
cyclopia in the slightly larger stage 9 treated embryo. This 
chick too showed blue staining in the limbs but not in the ribs 
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Figure 3. 11 day embryo with cyclopia stained with alcian blue. 
 
 
Figure 4. 11 day control embryo, stained with alcian blue. 
 
 
and very little in the spinal cord (Figure 3). In comparison, 
the control 11 day chicks showed alcian blue staining 
throughout (Figure 4), indicating that cartilage had formed in 
all the correct regions. 
 
Incidence of Cyclopia 
Cyclopia was observed in one of the chicks treated at stage 
9, the same one that developed further than the other 
treated animals. This can clearly be seen in Figure 5, which 
shows a frontal view of a control 11 day embryo stained with 
alcian blue that clearly has two eyes and a treated 11 day 
embryo that only has one eye. This can be seen in Figure 6.  
This embryo’s one eye is not exactly in the middle of its head 
but more off to the right side. It was not possible to see other 
facial abnormalities in this chick, and we were not able to tell 
if it had holoprosencephaly or not. Some of the treated 
animals appeared to have only one eye, but since they were 
so small and did not develop correctly, this was hard to tell. 
Perhaps if they had developed further, cyclopia would have 
been observed in these animals as well. 
 
Discussion 
 
From our experiment, we were able to confirm certain 
aspects of our hypothesis. We believed that inhibition of Shh 
signaling with cyclopamine could prevent correct patterning 
of the ventral tube, leading to a variety of facial 
Figure 5. Frontal view of 11 day control embryo stained with alcian 
blue, with two eyes indicated by arrows. 
 
 
 
Figure 6. Frontal view of 11 day treated chick with cyclopia, stained 
with alcian blue. Arrow indicates the presence of only one eye. 
 
malformations, including holoprosencephaly and cyclopia. 
While cyclopia was only induced in one of the cyclopamine 
treated chicks with certainty, we believe that if some of the 
others had developed further, they might have been shown 
to have had cyclopia as well. The success rate of our 
experiment was low. We expected to see more chicks 
develop to the same stage as the stage 9 treated embryo 
with cyclopia. Perhaps the low success rate was due to a too 
high of dose of cyclopamine. Much of the literature explored 
used this dose; one paper mentioned that any dose higher 
than 5µg was lethal to chicks in all cases. However, lower 
doses did induce cyclopia as well (9). Another difference in 
viability could also be due to the way cyclopamine was 
administered. In the first group of animals, we simply use a 
pipette to transfer the cyclopamine onto the vitelline 
membrane. However, when the success rate using this 
method was low, we injected cyclopamine through a hole in 
the vitelline membrane. We cannot say whether this was a 
better method or not. There was no survival of chicks in the 
stage 1 administration group, and only two chicks survived in 
the stage 9 administration group. However, there was one 
chick with cyclopia in this group. It seems that treating chicks 
at stage 9 is more successful in general, but this experiment 
would need to be repeated in order to confirm this. 
We also confirmed the part of our hypothesis that 
cartilage formation would not occur in cyclopamine treated 
embryos. While only one embryo developed large enough to 
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clearly see alcian blue staining, it was very clear that there 
was very little cartilage formation of the rib cage and 
vertebrae. As we proposed in our hypothesis, we think this is 
due to the fact that the somites, from which the vertebrae 
and ribs arise, did differentiate correctly due to aberrant Shh 
signaling.  
 Our experiment was limited in several ways. First 
of all, when we ran the first group of eggs, they had been 
sitting in the 13°C incubator for an extended amount of time. 
Ideally, we would have treated the eggs as soon as they had 
arrived. The longer the eggs spend fertilized but in an 
environment with too low of a temperature for them to grow, 
the less the eggs will start to develop once placed in a warm 
enough environment. However, for the second group of 
animals we ran, we did not experience a higher success rate 
of development, and we treated these eggs almost as soon 
as they arrived. Another limitation was the way we handled 
the control eggs. These were left untreated as well as 
unwindowed. Therefore, it is not possible to compare viability 
rates between the treated and control eggs. Windowing the 
eggs can be stressful to them and can cause damage, 
including death. While we tried to clean the eggs and 
supplies we touched with a 70% alcohol solution, the 
windowing process cannot be completely sterile. 
Embryos that were treated may have died not due 
to the effects of cyclopamine but due to the windowing 
process. For example, the egg yolk could have been 
punctured while removing liquid from the egg, or a bacterial 
infection could have taken over due to the use of 
contaminated syringes or pipettes. Another difference 
between the treated and control eggs was the use of HBC. 
While HBC was merely used to make cyclopamine more 
soluble in DPBS, it could have affected chick development in 
some way. This is unlikely, but the control eggs should have 
been windowed and treated with HBC-DPBS in order to 
ensure more reliable results. 
 
Conclusion 
 
While the incidence of cyclopia in our experiment was very 
low, we were able to establish that Shh signaling is crucial 
for chick development in more ways than we addressed in 
this experiment. We were able to observe that Shh signaling 
is crucial for the differentiation of the eye and of the ventral 
midline. Absence of Shh signaling can lead to 
holoprosencephaly and cyclopia. We also confirmed that 
Shh signaling is necessary for cartilage and consequent 
bone formation of the vertebrae and ribs. The fact that Shh 
signaling controls somite differentiation is most likely the 
reason why these structures did not develop correctly. 
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